Common Contracts
5 similar Employment Agreement contracts by Unity Biotechnology, Inc.
UNITY BIOTECHNOLOGY, INC. AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2020 • Unity Biotechnology, Inc. • Pharmaceutical preparations
THIS AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of March 9, 2020 (the “Effective Date”), by and between Unity Biotechnology, Inc., a Delaware corporation (“Company”) and Tamara L. Tompkins (“Executive”).
UNITY BIOTECHNOLOGY, INC. AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2020 • Unity Biotechnology, Inc. • Pharmaceutical preparations
THIS AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of March 9, 2020 (the “Effective Date”), by and between Unity Biotechnology, Inc., a Delaware corporation (“Company”) and Nathaniel E. David (“Executive”).
UNITY BIOTECHNOLOGY, INC. AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2020 • Unity Biotechnology, Inc. • Pharmaceutical preparations
THIS AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of March 9, 2020 (the “Effective Date”), by and between Unity Biotechnology, Inc., a Delaware corporation (“Company”) and Jamie Dananberg (“Executive”).
UNITY BIOTECHNOLOGY, INC. AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2020 • Unity Biotechnology, Inc. • Pharmaceutical preparations
THIS AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of March 9, 2020 (the “Effective Date”), by and between Unity Biotechnology, Inc., a Delaware corporation (“Company”) and Daniel G. Marquess (“Executive”).
UNITY BIOTECHNOLOGY, INC. AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2020 • Unity Biotechnology, Inc. • Pharmaceutical preparations
THIS AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of March 9, 2020 (the “Effective Date”), by and between Unity Biotechnology, Inc., a Delaware corporation (“Company”) and Robert C. Goeltz II (“Executive”).
